Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001213900-26-067154 <b>Size:</b> 2 MB

New Form N-CEN - ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001410368-26-057632 <b>Size:</b> 63 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028697 <b>Size:</b> 699 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001213900-26-067152 <b>Size:</b> 2 MB

Net Asset Value(s)

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001193125-26-265257 <b>Size:</b> 443 KB

Net Asset Value(s)

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

New Form FWP - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001193125-26-265254 <b>Size:</b> 66 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001213900-26-067150 <b>Size:</b> 2 MB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001140361-26-024745 <b>Size:</b> 417 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028689 <b>Size:</b> 987 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016212 <b>Size:</b> 422 KB

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016213 <b>Size:</b> 291 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Mariel von Schumann